Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer

Clinical Cancer Research

Volumn 10, Issue 19, 2004, Pages 6449-6455

  Yamamoto, Yoshiaki ^a   Matsuyama, Hideyasu ^a   Furuya, Tomoko ^a   Oga, Atsunori ^a   Yoshihiro, Satoru ^a   Okuda, Masaru ^b   Kawauchi, Shigeto ^a   Sasaki, Kohsuke ^a   Naito, Katsusuke ^a,b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; TUMOR MARKER;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BLADDER CANCER; CANCER GROWTH; CENTROSOME; CHROMOSOME 17; CHROMOSOME 20Q; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CENTROSOME; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 5144233514     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0773     Document Type: Article

References (26)

1. Ross JS, Cohen MB. Ancillary methods for the detection of recurrent urothelial neoplasia. Cancer (Phila) 2000;90:75-86.
2. Skacel M, Fahmy M, Brainard JA, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003;169:2101-5.
3. Sarkis AS, Dalbagni G, Cordon-Cardo C, et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst (Bethesda) 1993;85:53-9.
4. Lange BM, Gull K. Structure and function of the centriole in animal cells: progress and questions. Trends Cell Biol 1996;6:348-52.
5. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science (Wash DC) 1996;271:1744-7.
6. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature (Lond) 1997;386:623-7.
7. Lingle WL, Barrett SL, Negron VC, et al. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 2002;99:1978-83.
8. Pihan GA, Wallace J, Zhou Y, Doxsey SJ. Centrosome abnormalities and chromosome instability occur together in preinvasive carcinomas. Cancer Res 2003;63:1398-404.
9. Sen S, Zhou H, Zhang RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst (Bethesda) 2002;94:1320-9.
10. Zhou H, Kuang J, Zhong L, et al. Tumour amplified kinase STK15/ BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998;20:189-93.
11. Jiang F, Caraway NP, Sabichi AL, et al. Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer 2003;106:661-5.
12. Kawamura K, Moriyama M, Shiba N, et al. Centrosome hyperamplification and chromosomal instability in bladder cancer. Eur Urol 2003;43:505-15.
13. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumors. Geneva: WHO; 1973.
14. Sobin L, Wittekind C. UICC TNM classification of malignant tumors. 6th ed. [revised]. New York: Wiley; 2002. p. 199-202.
15. Harada T, Okita K, Shiraishi K, et al. Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. Cancer Res 2002;62:835-39.
16. Okuda M, Horn HF, Tarapore P, et al. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 2000;103: 127-40.
17. Sasaki K, Kurose A, Miura Y, Sato T, Ikeda E. DNA ploidy analysis by laser scanning cytometry (LSC) in colorectal cancers and comparison with flow cytometry. Cytometry 1996;23:106-9.
18. Furuya T, Kamada T, Murakami T, Kurose A, Sasaki K. Laser scanning cytometry allows detection of cell death with morphological features of apoptosis in cells stained with PI. Cytometry 1997; 29:173-7.
19. Hiddemann W, Schumann J, Andreef M, et al. Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet 1984;13:181-3.
20. Furuya T, Uchiyama T, Murakami T, et al. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers. Clin Cancer Res 2000;6:2815-20.
21. Li D, Zhu J, Firozi PF, et al. Overexpression of oncogenic STK15/ BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003;9:991-7.
22. Carroll PE, Okuda M, Horn HF, et al. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 1999;18:1935-44.
23. Matsuyama H, Bergerheim US, Nilsson I, et al. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 1994;77:118-24.
24. Tsukamoto M, Matsuyama H, Oba K, et al. Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence. Cancer Genet Cytogenet 2002;134:41-5.
25. Cavenee WK, Dryja TP, Phillips RA, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (Lond) 1983;305:779-84.
26. Goepfert TM, Adigun YE, Zhong L, et al. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res 2002;62:4115-22.